Statistics for Charles River Laboratories International (id:8871 CRL)
Valuation metrics
Market cap
9.59B
Enterprise value
12.20B
Trailing P/E (ttm)
23.38
Forward P/E
18.24
PEG ratio
18.24
Price/Sales (ttm)
2.36
Price/Book (mrq)
2.53
Enterprise Value/Revenue
3.00
Enterprise Value/EBITDA
12.86
Overview
Shares outstanding
51.14M
Float
50.54M
Shares short
1.85M
% Held by insiders
0.01%
% Held by institutions
1.04%
Average volume (10 days)
1.04M
Average volume (90 days)
Price summary
52-Week low
176.48
52-Week high
275.00
52-Week change
0.55%
Beta
1.38
50-Day moving average
195.26
200-Day moving average
219.72
Dividends and splits
Forward annual dividend rate
0.40
Forward annual dividend yield
0.00
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
Payout ratio
0.00
Dividend date
Ex-dividend date
November 28th, 1996
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 30th, 2023
Most recent quarter (mrq)
September 30th, 2024
Profitability
Profit margin
10.44%
Operating margin
14.69%
Operational effectiveness
Return on assets
4.87%
Return on equity
11.92%
Income statement
Revenue (ttm)
78.97
Revenue per share (ttm)
78.97
Quarterly revenue growth (yoy)
-0.20
Gross profit (ttm)
1.50B
EBITDA
990.36M
Net income to common (ttm)
413.08M
Diluted EPS (ttm)
8.02
Quarterly earnings growth (yoy)
-20.30%
Balance sheet
Total cash (mrq)
210.17M
Total cash per share (mrq)
4.11
Total debt (mrq)
2.76B
Total Debt/Equity (mrq)
72.18
Current ratio (mrq)
147.70%
Book value per share (mrq)
73.97
Cash flow
Cash flow statement
796.16M
Levered free cash flow (LFCF)
495.27M